Mon, Dec 29, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Regulatory roundup: Current U.S. law, commodities, tax developments affecting hedge funds

Monday, March 15, 2010

Benedicte Gravrand, Opalesque London:

The following information was given out at a seminar in London last week organised by Katten Muchin Rosenman LLP, a U.S. law firm with an affiliate in London that specialises in corporate, financial services, litigation, real estate, commercial finance, intellectual property and trusts and estates.

U.S. regulatory structure and current legislative developments affecting hedge funds and proprietary firms

The current U.S. regulatory structure for hedge funds and proprietary trading firms includes:

I - Investment Company Act of 1940 - requires non-exempt investment companies to register with the SEC.

II - Commodity Exchange Act - requires non-exempt operators and advisory commodity pools to register.

III - Investment Advisers Act of 1940 - requires non-exempt advisers to register with the SEC.

IV - Securities Exchange Act of 1934 - requires registration of non-exempt broker-dealers (note: some hedge funds form a "captive" broker-dealer status for marketing purposes.)

V - Securities Act 1933 - requires registration of non-exempt securities that are offered to the public. Most hedge funds rely on the private placement exemption in connection with the offering of interests in the fund (and marketing must comply with Reg D).

Current U.S. securities law developments

......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its